NGUYEN LE: Open Payments
NPI 1538787056 · REDLANDS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$504 in 20 payments from 5 companies in 2025. Trend: 2023 $23 · 2024 $242 · 2025 $504
Food & beverage: $504
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $159 |
| GENZYME CORPORATION | 4 | $134 |
| Madrigal Pharmaceuticals | 1 | $121 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
Products named: DUPIXENT, CREON, REZDIFFRA, LINZESS, XIFAXAN.
Industry payments across CA — which companies pay providers there.
